Gastro-Hep News

Guidelines Released for the Diagnosis and Treatment of Achalasia The American College of Gastroenterology released guidelines on the diagnosis and treatment of achalasia, including recommendations, key […]

Gastro-Hep News

US Food and Drug Administration Approves Teduglutide for Pediatric Patients With Short Bowel Syndrome On May 17, 2019, the US Food and Drug Administration (FDA) expanded […]

Gastro-Hep News

Liquid Biopsies Show Potential in Detecting Early-Stage Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection Liquid biopsies, based on a combination of cell-free DNA (cfDNA) […]

Gastro-Hep News

Diet Low in Sugar Improves Nonalcoholic Fatty Liver Disease in Adolescent Patients Compared to a standard diet, a diet low in free sugars led to a […]

Review of Regorafenib for the Treatment of Hepatocellular Carcinoma

G&H Why was there a need for a new hepatocellular carcinoma treatment before regorafenib? RF For the past 10 years, only 1 drug has shown […]

Occurrence and Recurrence of Hepatocellular Carcinoma After Successful Direct-Acting Antiviral Therapy for Patients With Chronic Hepatitis C Virus Infection

Abstract: Chronic hepatitis C virus (HCV) infection has generally been associated with a slightly increased risk of developing hepatocellular carcinoma (HCC). For the past several […]

Gastro-Hep News

US Food and Drug Administration Approves Infliximab Biosimilar On April 21, 2017, the US Food and Drug Administration (FDA) approved infliximab-abda (Renflexis, Samsung Bioepis), an infliximab […]

The Possible Association Between DAA Treatment for HCV Infection and HCC Recurrence

Gastroenterology & Hepatology Volume 12, Issue 12, December 2016 Robert S. Brown, Jr, MD, MPH Gladys and Roland Harriman Professor of Medicine Clinical Chief, Division of […]

Liver Transplant and Hepatocellular Carcinoma

G&H How are donor livers currently allocated to patients in need of a transplant? RW The current allocation system for patients with chronic liver disease […]